British American Tobacco Ups Its Organigram Stake; Curaleaf Slips On Rumors
Investing.com | Mar 08, 2022 08:35
One of the largest tobacco companies in the world increased its ownership position in a small Canadian cannabis company last week as part of a deal struck one year ago.
British American Tobacco (NYSE:BTI) invested an additional C$6.3 million ($4.9 million) in New Brunswick-based Organigram Holdings (NASDAQ:OGI) (TSX:OGI), upping its stake to 19.5% from 18.8%.
The move is part of the deal the two companies initiated in March 2021 that provides for periodic “top-up” investments following share issuances. Last December, Organigram issued 11 million shares to finance the acquisition of Laurentian Organic, a Quebec-based craft cannabis company. BAT purchased just over 2.6 million of those shares at an average price of $2.3868, according to a statement released by the companies.
The news gave shares of the Organigram, which specializes in recreational and medical cannabis offerings, a small boost. The stock jumped from a low two weeks ago of about $1.40 a share to about $1.50 a share on the news. But by the end of last week, Organigram closed at $1.38, down just over 2% on the day on Friday, and a drop of 1.4% since the announcement.
Yesterday, shares of Organigram closed at $1.31, down another 5% on the day. In the last 12 months, shares of the company have lost 48.5%.
h2 The Cost Of War And Rumors/h2It’s been a tough few weeks for Curaleaf Holdings (OTC:CURLF). The US-based cannabis company made an unprecedented move—perhaps a reflection of the unprecedented times.
In a statement to investors the marijuana giant said:
“Curaleaf would like to provide some clarity by addressing speculation regarding how the Russia-Ukraine crisis may impact the company.”
It went on to explain:
“The speculation on social media that the Company and its major shareholders and executives will somehow be subject to any US government economic sanctions now or in the future is incorrect.”
The statement outlined specifics that included that the company’s executive chairman and largest shareholder, Boris Jordan, “is an American citizen, born and raised on Long Island, New York. He is not, and has never been, a citizen of any other country.”
And that the company’s second-largest shareholder, Andrei Blokh, “is a US citizen, who also holds a Russian passport.”
Get The App
Blokh is reported to hold a 21% stake in the company.
The aim of the statement was to clearly state that the company’s executives and shareholders are not affected by the US government’s sanctions imposed on Russia.
Shares of Curaleaf have lost 26.8% since Feb. 24, the day Russian forces invaded Ukraine, dropping from $7.49 to $5.48 at yesterday’s close.
On Mar. 3, the Massachusetts-based Curaleaf presented its fourth quarter and year-end results that included two record line items. The company’s fiscal year 2021 set new revenue and adjusted EBITDA records of $1.2 billion and $298 million, respectively.
These figures represented gains of 93% for revenue and 107% for EBITDA.
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.